arrow
Back
E

Erik P. Sulman

new york university

75H-index
660Paper Count
3.3WCitation Count
Published Papers 252
Publication Date
NANP targeting radiosensitizes glioblastoma through TNFR1 sialylation-driven mesenchymal shift
err2026-03-18
err0
errOAAI
errYingwen Ding; Ze-Yan Zhang; Ravesanker Ezhilarasan; Aram S. Modrek; Melanie Graciani; Jerome Karp; Graysen McManus; Ananya Jambhale; Erik P. Sulman
errShare
errSave
Neurocognitive outcomes in patients with brain metastases: a systematic review
err2025-11-24
err0
PREAI
errTarek Bou Dargham; Sebastian F Winter; Kristen Batich; Karin Gehring; Michael W Parsons; Jorg Dietrich; Trey Mullikin; Zachary J Reitman; Scott R Floyd; John P Kirkpatrick; Paul W Sperduto; Jona Hattangadi-Gluth; Helen A Shih; Paul D Brown; Minesh Mehta; Erik P Sulman; Katherine B Peters; Eugene J Vaios
errShare
errSave
IMG-72. [68Ga]Ga-DOTA-TATE PET as imaging biomarker for response assessment and monitoring in patients receiving [177Lu]Lu-DOTA-TATE for advanced intracranial meningioma
err2025-11-11
err0
errOAAI
errSylvia C Kurz; Elcin Zan; David Peereboom; Christine Cordova; Mina Lobbous; Marissa Barbaro; Mark Malkin; Alexandra Miller; Andrew Dhawan; Joshua S Silverman; Matija Snuderl; David Zagzag; John G Golfinos; Douglas Kondziolka; Andrea B Troxel; Kent P Friedman; Erik P Sulman; Timothy M Shepherd
errShare
errSave
TIP-15. Trial in progress: phase IB study of concurrent Azeliragon, a RAGE inhibitor, with craniospinal irradiation in patients with leptomeningeal metastases
err2025-11-11
err0
errOAAI
errKara M Banson; Judith D Goldberg; Benjamin T Cooper; Joshua Silverman; Erik P Sulman; Stephen Marcus; Marissa Barbaro; J Ricardo McFaline-Figueroa; Maria del Pilar Guillermo Prieto Eibl; Alexandra M Miller; Jonathan T Yang
errShare
errSave
Genomic and Epigenomic Signatures Can Distinguish Aggressive Chromophobe Renal Cell Carcinoma from Indolent Renal Oncocytic Tumors in Clinical-grade Samples
err2025-11-04
err0
PREAI
errRoberto Ruiz-Cordero; Qi Wang; Gayatri Kumar; Mahmut Akgul; Chad J. Creighton; Priya Rao; Pheroze Tamboli; Lan Zheng; Jianping Zhao; Paari Murugan; Steven Shen; Fadi Brimo; Ravesanker Ezhilarasan; Erik Sulman; Khalida Wani; Alexander J. Lazar; Taebeom Kim; Ken Chen; Krishna P.L. Bhat; Kasthuri Kannan; Jing Wang; Jose A. Karam; Kanishka Sircar
errShare
errSave
A METHYLATION-SIGNATURE OF RADIATION RESPONSE IN GLIOBLASTOMA
err2025-11-01
err0
errOAAI
errJambhale, Ananya; Ezhilarasan, Ravesanker; Karp, Jerome; Sulman, Erik
errShare
errSave
Anti-Robo1/2 monoclonal antibodies as a novel macrophage-based immunotherapy for glioblastoma
err2025-11-01
err0
errOAAI
errGeraldo, Luiz Henrique Medeiros; De Oliveira, Maria Luiza Lopes; Blazer, Levi; Sulman, Erik; Figueroa, Jose Ricardo McFaline; Sidhu, Sachdev; Lund, Amanda
errShare
errSave
Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma
err2025-11-01
err0
errOAAI
errLim, Michael; Berry, Donald; Berry, Nicholas; Colman, Howard; De Groot, John; Ellingson, Benjamin; Gan, Hui; Hyddmark, E. Viktoria; Johnson, Adam; Lassman, Andrew; Mellinghoff, Ingo; Perry, James; Sulman, Erik; Weller, Michael; Wen, Patrick; Cloughesy, Timothy; Network, Gbm Agile Trial
errShare
errSave
RESULTS OF A SINGLE-ARM, OPEN-LABEL, MULTICENTER PHASE 2 STUDY OF THE RADIOPHARMACEUTICAL [177LU]LU-DOTA-TATE IN ADULTS WITH ADVANCED INTRACRANIAL MENINGIOMA
err2025-11-01
err0
errOAAI
errKurz, Sylvia C.; Zan, Elcin; Cordova, Christine; Lobbous, Mina; Barbaro, Marissa; Malkin, Mark; Miller, Alexandra M.; Dhawan, Andrew; Torres-Trejo, Alejandro; Stevens, Glen; Silverman, Joshua S.; Snuderl, Matija; Zagzag, David; Golfinos, John G.; Kondziolka, Douglas; Shepherd, Timothy M.; Troxel, Andrea B.; Friedman, Kent P.; Sulman, Erik P.
errShare
errSave
MOMENTUM-1: a multicenter, randomized, open-label, phase 2 study of [177Lu]Lu-DOTA-TATE in adults with progressive grade 1-3 meningioma (RTOG 3523)
err2025-11-01
err0
errOAAI
errKurz, Sylvia C.; Rabbee, Nusrat; Wen, Patrick Y.; Kalapurakal, John A.; Peereboom, David M.; Bi, Linda W.; Huang, Raymond; Ivanidze, Jana; Perry, Arie; Cahill, Jennifer; Johnson, Derek R.; Mehta, Minesh; Sulman, Erik P.
errShare
errSave
A novel, pooled, high-throughput screening of a CNS penetrant compound library identifies potential biomarker-driven therapeutics for glioblastoma
err2025-11-01
err0
errOAAI
errDing, Yingwen; McManus, Graysen; Zhang, Ze-Yan; Ezhilarasan, Ravesanker; Graciani, Melanie; Jambhale, Ananya; Modrek, Aram; Karp, Jerome; Sulman, Erik P.
errShare
errSave
B A NOVEL, POOLED, HIGH-THROUGHPUT SCREENING OF A CNS PENETRANT COMPOUND LIBRARY IDENTIFIES POTENTIAL BIOMARKER-DRIVEN THERAPEUTICS FOR GLIOBLASTOMA
err2025-10-01
err0
errOAAI
errSulman, E. P.; Zhang, Z.; Ding, Y.; Ezhilarasan, R.; Graciani, M.; McManus, G.; Modrek, A.; Karp, J.
errShare
errSave
Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825
err2024-11-16
err0
PREAI
errStrauss, Joshua D.; Gilbert, Mark R.; Mehta, Minesh; Li, Ang; Zhou, Renke; Bondy, Melissa L.; Sulman, Erik P.; Yuan, Ying; Liu, Yanhong; Vera, Elizabeth; Wendland, Merideth M.; Stieber, Volker W.; Puduvalli, Vinay K.; Choi, Serah; Martinez, Nina L.; Robins, H. Ian; Hunter, Grant K.; Lin, Chi-Fan; Guedes, Vivian A.; Richard, Melissa A.; Pugh, Stephanie L.; Armstrong, Terri S.; Scheurer, Michael E.
errShare
errSave
EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
err2024-11-11
err0
PREAI
errMellinghoff, Ingo K.; Cloughesy, Timothy; Alexander, Brian; Berry, Donald A.; Buxton, Meredith; Cavenee, Webster; Colman, Howard; de Groot, John; Ellingson, Benjamin M.; Gordon, Gary B.; Lassman, Andrew B.; Lim, Michael; Khasraw, Mustafa; Perry, James; Sulman, Erik P.; Weller, Michael; Wen, Patrick; Yung, W. K. Alfred; Berry, Nicholas; Graves, Todd; Detry, Michelle; Hyddmark, E. M. Viktoria; Johnsson, Adam; Kling, Heather; Mcglothlin, Anna; Powell, Ashley; Untch, Sarah; Aquilanti, Elisa; Blondin, Nicholas; Boulmay, Brian; de la Fuente, Macarena; Drappatz, Jan; Jordan, Justin; Kaley, Thomas J.; Lobbous, Mina; Mikkelsen, Tom; Newton, Herbert; Owen, Scott; Peters, Katherine; Schiff, David; Sherman, Wendy; Weathers, Shiao-Pei; Youssef, Michael; Friend, John; Lee, Eudocia
errShare
errSave
A FACILE HIGH THROUGHPUT DRUG SCREENING PLATFORM ENABLES THE CONSTRUCTION OF A PHARMACO-PROTEOGENOMIC INTERACTION LANDSCAPE IN GLIOBLASTOMA
err2024-11-11
err0
PREAI
errZhang, Ze-Yan; Ding, Yingwen; Ezhilarasan, Ravesanker; Graciani, Melanie; Modrek, Aram; Karp, Jerome; Sulman, Erik
errShare
errSave
Point/Counterpoint: The role of reirradiation in recurrent glioblastoma
err2024-11-11
err0
PREAI
errRahman, Rifaquat; Preusser, Matthias; Tsien, Christina; Le Rhun, Emilie; Sulman, Erik P.; Wen, Patrick Y.; Minniti, Giuseppe; Weller, Michael
errShare
errSave
UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
err2024-11-11
err0
PREAI
errLassman, Andrew; Alexander, Brian; Berry, Donald; Berry, Nicholas; Buxton, Meredith; Colman, Howard; Gan, Hui; de Groot, John; de la Fuente, Macarena; Drappatz, Jan; Ducray, Francois; Ellingson, Benjamin; Gordon, Gary; Hyddmark, Emma; Johnson, Adam; Khasraw, Mustafa; Lee, Eudocia; Lim, Michael; Mcglothlin, Anna; Mellinghoff, Ingo; Mikkelsen, Tom; Nghiemphu, Phioanh; Perry, James; Powell, Ashley; Sulman, Erik; Tanner, Krik; Untch, Sarah; Weller, Michael; Wen, Patrick; Wick, Antje; Yung, Alfred; Cloughesy, Timothy
errShare
errSave
OUTCOMES OF RADIOSURGERY FOR WHO GRADE 2 MENINGIOMAS: THE ROLE OF KI-67 INDEX IN GUIDING THE TUMOR MARGIN DOSE
err2024-11-11
err0
PREAI
errMeng, Ying; Bernstein, Kenneth; Mashiach, Elad; Santhumayor, Brandon; Kannapadi, Nivedha; Gurewitz, Jason; Snuderl, Matija; Pacione, Donato; Sen, Chandra; Donahue, Bernadine; Silverman, Joshua; Sulman, Erik; Golfinos, John; Kondziolka, Douglas
errShare
errSave